Repeated Administration of Recombinant Human Serum Albumin Caused No Serious Allergic Reactions in Patients with Liver Cirrhosis: a Multicenter Clinical Study

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2008 Jul 5

PMID 18600391

Citations 5

Authors

Akinori Kasahara

Keiji Kita

Eiichi Tomita

Jouji Toyota

Yasuharu Imai

Hiromitsu Kumada

Affiliations

Soon will be listed here.

Abstract

Background: We carried out a multicenter study to evaluate the safety of recombinant human serum albumin (rHSA), developed using the methylotrophic yeast Pichia pastoris, during and after repeated administration in patients with liver cirrhosis.

Methods: rHSA was administered to 423 cirrhosis patients with ascites or edema. rHSA was administered three times over 3 days, and each 3-day treatment course was repeated at least three times with an interval of at least 2 weeks between courses. Adverse drug reactions (ADRs) were monitored during and after repeated rHSA administration. Specific antibody titers against Pichia yeast components were measured before and after treatment. Efficacy was evaluated on the basis of changes in serum albumin level, colloid osmotic pressure, and body weight.

Results: ADRs were observed in 96 of 423 patients (22.7%), with no serious allergy or difference in the incidence of ADRs observed among the first, second, and third administrations. Specific IgE and IgG antibodies were detected before treatment in 19 and 422 patients, respectively. However, allergic ADRs were observed in 14 patients in whom specific IgE antibodies were not detected. No obvious relationship between allergic ADRs and specific IgE or IgG titers was identified. Serum albumin levels and colloid osmotic pressure increased significantly (P < 0.0001), and body weight decreased significantly (P < 0.0001) after rHSA administration.

Conclusions: rHSA caused no serious allergic reactions even when three treatment courses were administered at intervals of at least 2 weeks.

Citing Articles

Evaluation of the potential food allergy risks of human lactoferrin expressed in .

Anaya Y, Rosario Martinez R, Goodman R, Johnson P, Vajpeyi S, Lu X Front Immunol. 2024; 15:1380028.

PMID: 39114650 PMC: 11303282. DOI: 10.3389/fimmu.2024.1380028.

Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan.

Sakaida I, Nakajima K, Okita K, Hori M, Izumi T, Sakurai M J Gastroenterol. 2015; 50(10):1047-53.

PMID: 25689936 PMC: 4592499. DOI: 10.1007/s00535-015-1052-5.

Immunotoxicity assessment of rice-derived recombinant human serum albumin using human peripheral blood mononuclear cells.

Fu K, Cheng Q, Liu Z, Chen Z, Wang Y, Ruan H PLoS One. 2014; 9(8):e104426.

PMID: 25099245 PMC: 4123919. DOI: 10.1371/journal.pone.0104426.

Technetium-99m-labeled autologous serum albumin: a personal-exclusive source of serum component.

Wang Y, Chen Y, Li D, Chuang M J Biomed Biotechnol. 2011; 2011:413802.

PMID: 21541233 PMC: 3085401. DOI: 10.1155/2011/413802.

Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome.

Tsuruga K, Oki E, Yashiro T, Ito E, Tanaka H Pediatr Nephrol. 2009; 24(11):2275-6.

PMID: 19475428 DOI: 10.1007/s00467-009-1221-y.

References

Kobayashi K, Kuwae S, Ohya T, Ohda T, Ohyama M, Ohi H . High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. J Biosci Bioeng. 2005; 89(1):55-61. DOI: 10.1016/s1389-1723(00)88050-0. View

Soderstrom L, Kober A, Ahlstedt S, De Groot H, Lange C, Paganelli R . A further evaluation of the clinical use of specific IgE antibody testing in allergic diseases. Allergy. 2003; 58(9):921-8. DOI: 10.1034/j.1398-9995.2003.00227.x. View

Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K . Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999; 12(6):439-46. DOI: 10.1093/protein/12.6.439. View

Lusher J, Abildgaard C, Arkin S, Mannucci P, Zimmermann R, Schwartz L . Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation. J Thromb Haemost. 2004; 2(4):574-83. DOI: 10.1111/j.1538-7933.2004.00646.x. View

Ewan P, Coote D . Evaluation of a capsulated hydrophilic carrier polymer (the ImmunoCAP) for measurement of specific IgE antibodies. Allergy. 1990; 45(1):22-9. DOI: 10.1111/j.1398-9995.1990.tb01080.x. View

Kobayashi K, Nakamura N, Sumi A, Ohmura T, Yokoyama K . The development of recombinant human serum albumin. Ther Apher. 1999; 2(4):257-62. DOI: 10.1111/j.1744-9987.1998.tb00118.x. View

Ahlstedt S . Understanding the usefulness of specific IgE blood tests in allergy. Clin Exp Allergy. 2002; 32(1):11-6. DOI: 10.1046/j.0022-0477.2001.01289.x. View

White 2nd G, Courter S, Bray G, Lee M, Gomperts E . A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study Group. Thromb Haemost. 1997; 77(4):660-7. View

TULLIS J . Albumin. 2. Guidelines for clinical use. JAMA. 1977; 237(5):460-3 concl. DOI: 10.1001/jama.237.5.460. View

10.

Vermeulen Jr L, Ratko T, Erstad B, Brecher M, Matuszewski K . A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med. 1995; 155(4):373-9. DOI: 10.1001/archinte.155.4.373. View

11.

Ikegaya K, Hirose M, Ohmura T, Nokihara K . Complete determination of disulfide forms of purified recombinant human serum albumin, secreted by the yeast Pichia pastoris. Anal Chem. 1997; 69(11):1986-91. DOI: 10.1021/ac961316l. View

12.

Kobayashi K . Summary of recombinant human serum albumin development. Biologicals. 2006; 34(1):55-9. DOI: 10.1016/j.biologicals.2005.08.021. View

13.

Ohtani W, Nawa Y, Takeshima K, Kamuro H, Kobayashi K, Ohmura T . Physicochemical and immunochemical properties of recombinant human serum albumin from Pichia pastoris. Anal Biochem. 1998; 256(1):56-62. DOI: 10.1006/abio.1997.2480. View